{"entity":{"type":"insider","cik":"0001330564","url":"/insider/0001330564","json_url":"/insider/0001330564.json","name":"Chaumiere Consultadoria & Servicos SDC Unipessoal LDA","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":19,"n_filings":10,"first":"2006-12-22","last":"2009-10-13","span_basis":"filed_date"},"name_variants":[{"name":"Chaumiere Consultadoria & Servicos SDC Unipessoal LDA","source":"filing","n_filings":10,"first_seen":"2006-12-22","last_seen":"2009-10-13"}],"transactions":[{"id":5816420,"accession":"0001140361-09-023062","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-09-023062","line_url":"/filing/0001140361-09-023062#line-1","is_derivative":false,"issuer_cik":"0000707511","issuer_name":"REGENERX BIOPHARMACEUTICALS INC","issuer_ticker":"RGN","issuer_name_source":null,"issuer_url":"/issuer/0000707511","owner_cik":"0001330564","owner_name":"Chaumiere Consultadoria & Servicos SDC Unipessoal LDA","owner_display_name":"Chaumiere Consultadoria & Servicos SDC Unipessoal LDA","owner_url":"/insider/0001330564","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1219512.0,"shares_display":"1,219,512","price_per_share":0.82,"price_display":"0.82","price_state":"stated","total_value":999999.84,"total_display":"999,999.84","total_whole":"1,000,000","shares_owned_after":8175110.0,"shares_owned_after_display":"8,175,110","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-08","filed_date":"2009-10-13","scope":"insider"},{"id":5588170,"accession":"0001140361-09-014001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-09-014001","line_url":"/filing/0001140361-09-014001#line-1","is_derivative":false,"issuer_cik":"0000707511","issuer_name":"REGENERX BIOPHARMACEUTICALS INC","issuer_ticker":"RGN","issuer_name_source":null,"issuer_url":"/issuer/0000707511","owner_cik":"0001330564","owner_name":"Chaumiere Consultadoria & Servicos SDC Unipessoal LDA","owner_display_name":"Chaumiere Consultadoria & Servicos SDC Unipessoal LDA","owner_url":"/insider/0001330564","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":312500.0,"shares_display":"312,500","price_per_share":0.4,"price_display":"0.40","price_state":"stated","total_value":125000.0,"total_display":"125,000.00","total_whole":"125,000","shares_owned_after":6955598.0,"shares_owned_after_display":"6,955,598","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-06-02","filed_date":"2009-06-04","scope":"insider"},{"id":5709092,"accession":"0001140361-09-009600","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-09-009600","line_url":"/filing/0001140361-09-009600#line-1","is_derivative":false,"issuer_cik":"0000707511","issuer_name":"REGENERX BIOPHARMACEUTICALS INC","issuer_ticker":"RGN","issuer_name_source":null,"issuer_url":"/issuer/0000707511","owner_cik":"0001330564","owner_name":"Chaumiere Consultadoria & Servicos SDC Unipessoal LDA","owner_display_name":"Chaumiere Consultadoria & Servicos SDC Unipessoal LDA","owner_url":"/insider/0001330564","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1052631.0,"shares_display":"1,052,631","price_per_share":0.57,"price_display":"0.57","price_state":"stated","total_value":599999.67,"total_display":"599,999.67","total_whole":"600,000","shares_owned_after":6643098.0,"shares_owned_after_display":"6,643,098","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-04-13","filed_date":"2009-04-15","scope":"insider"},{"id":2378425,"accession":"0001140361-08-027711","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-08-027711","line_url":"/filing/0001140361-08-027711#line-1","is_derivative":false,"issuer_cik":"0000707511","issuer_name":"REGENERX BIOPHARMACEUTICALS INC","issuer_ticker":"RGN","issuer_name_source":null,"issuer_url":"/issuer/0000707511","owner_cik":"0001330564","owner_name":"Chaumiere Consultadoria & Servicos SDC Unipessoal LDA","owner_display_name":"Chaumiere Consultadoria & Servicos SDC Unipessoal LDA","owner_url":"/insider/0001330564","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1034482.0,"shares_display":"1,034,482","price_per_share":1.45,"price_display":"1.45","price_state":"stated","total_value":1499998.9,"total_display":"1,499,998.90","total_whole":"1,499,999","shares_owned_after":5590467.0,"shares_owned_after_display":"5,590,467","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-12-10","filed_date":"2008-12-12","scope":"insider"},{"id":3714444,"accession":"0001209191-08-047318","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-08-047318","line_url":"/filing/0001209191-08-047318#line-1","is_derivative":false,"issuer_cik":"0000891288","issuer_name":"QUESTCOR PHARMACEUTICALS INC","issuer_ticker":"QCOR","issuer_name_source":null,"issuer_url":"/issuer/0000891288","owner_cik":null,"owner_name":"Chaumiere Consultadoria & Servicos SDC Unipessoal LDA; APTAFIN S P A; CAVAZZA PAOLO","owner_display_name":"Chaumiere Consultadoria & Servicos SDC Unipessoal LDA","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, no par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2200000.0,"shares_display":"2,200,000","price_per_share":4.95,"price_display":"4.95","price_state":"stated","total_value":10890000.0,"total_display":"10,890,000.00","total_whole":"10,890,000","shares_owned_after":4908889.0,"shares_owned_after_display":"4,908,889","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-08-13","filed_date":"2008-08-14","scope":"insider"},{"id":3684275,"accession":"0001209191-08-042968","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-08-042968","line_url":"/filing/0001209191-08-042968#line-1","is_derivative":false,"issuer_cik":"0000891288","issuer_name":"QUESTCOR PHARMACEUTICALS INC","issuer_ticker":"QCOR","issuer_name_source":null,"issuer_url":"/issuer/0000891288","owner_cik":null,"owner_name":"CAVAZZA PAOLO; Chaumiere Consultadoria & Servicos SDC Unipessoal LDA; APTAFIN S P A","owner_display_name":"CAVAZZA PAOLO","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, no par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":4.9147,"price_display":"4.91","price_state":"stated","total_value":491470.0,"total_display":"491,470.00","total_whole":"491,470","shares_owned_after":7108889.0,"shares_owned_after_display":"7,108,889","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-07-16","filed_date":"2008-07-18","scope":"insider"},{"id":3774717,"accession":"0001209191-08-041525","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-08-041525","line_url":"/filing/0001209191-08-041525#line-1","is_derivative":false,"issuer_cik":"0000891288","issuer_name":"QUESTCOR PHARMACEUTICALS INC","issuer_ticker":"QCOR","issuer_name_source":null,"issuer_url":"/issuer/0000891288","owner_cik":null,"owner_name":"Chaumiere Consultadoria & Servicos SDC Unipessoal LDA; APTAFIN S P A; CAVAZZA PAOLO","owner_display_name":"Chaumiere Consultadoria & Servicos SDC Unipessoal LDA","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, no par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31338.0,"shares_display":"31,338","price_per_share":5.2,"price_display":"5.20","price_state":"stated","total_value":162957.6,"total_display":"162,957.60","total_whole":"162,958","shares_owned_after":7208889.0,"shares_owned_after_display":"7,208,889","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-07-02","filed_date":"2008-07-07","scope":"insider"},{"id":2940865,"accession":"0001209191-08-035888","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-08-035888","line_url":"/filing/0001209191-08-035888#line-2","is_derivative":false,"issuer_cik":"0000891288","issuer_name":"QUESTCOR PHARMACEUTICALS INC","issuer_ticker":"QCOR","issuer_name_source":null,"issuer_url":"/issuer/0000891288","owner_cik":null,"owner_name":"Chaumiere Consultadoria & Servicos SDC Unipessoal LDA; CAVAZZA PAOLO; APTAFIN S P A","owner_display_name":"Chaumiere Consultadoria & Servicos SDC Unipessoal LDA","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, no par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3900.0,"shares_display":"3,900","price_per_share":5.2,"price_display":"5.20","price_state":"stated","total_value":20280.0,"total_display":"20,280.00","total_whole":"20,280","shares_owned_after":7240227.0,"shares_owned_after_display":"7,240,227","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-06","filed_date":"2008-06-09","scope":"insider"},{"id":2940859,"accession":"0001209191-08-035888","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-08-035888","line_url":"/filing/0001209191-08-035888#line-1","is_derivative":false,"issuer_cik":"0000891288","issuer_name":"QUESTCOR PHARMACEUTICALS INC","issuer_ticker":"QCOR","issuer_name_source":null,"issuer_url":"/issuer/0000891288","owner_cik":null,"owner_name":"Chaumiere Consultadoria & Servicos SDC Unipessoal LDA; CAVAZZA PAOLO; APTAFIN S P A","owner_display_name":"Chaumiere Consultadoria & Servicos SDC Unipessoal LDA","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, no par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4100.0,"shares_display":"4,100","price_per_share":5.2,"price_display":"5.20","price_state":"stated","total_value":21320.0,"total_display":"21,320.00","total_whole":"21,320","shares_owned_after":7244127.0,"shares_owned_after_display":"7,244,127","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-05","filed_date":"2008-06-09","scope":"insider"},{"id":8141243,"accession":"0001209191-07-065902","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-07-065902","line_url":"/filing/0001209191-07-065902#line-2","is_derivative":false,"issuer_cik":"0000891288","issuer_name":"QUESTCOR PHARMACEUTICALS INC","issuer_ticker":"QSC","issuer_name_source":null,"issuer_url":"/issuer/0000891288","owner_cik":null,"owner_name":"DEFIANTE FARMACEUTICA LDA; APTAFIN S P A; SIGMA TAU FINANZIARIA SPA; CAVAZZA CLAUDIO; SIGMA TAU INTERNATIONAL SA; Inverlochy Consultadoria & Servicos L.D.A.; Chaumiere Consultadoria & Servicos SDC Unipessoal LDA; CAVAZZA PAOLO","owner_display_name":"DEFIANTE FARMACEUTICA LDA","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, no par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2446782.0,"shares_display":"2,446,782","price_per_share":4.68,"price_display":"4.68","price_state":"stated","total_value":11450939.76,"total_display":"11,450,939.76","total_whole":"11,450,940","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-20","filed_date":"2007-11-23","scope":"insider"},{"id":8141241,"accession":"0001209191-07-065902","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-07-065902","line_url":"/filing/0001209191-07-065902#line-1","is_derivative":false,"issuer_cik":"0000891288","issuer_name":"QUESTCOR PHARMACEUTICALS INC","issuer_ticker":"QSC","issuer_name_source":null,"issuer_url":"/issuer/0000891288","owner_cik":null,"owner_name":"DEFIANTE FARMACEUTICA LDA; APTAFIN S P A; SIGMA TAU FINANZIARIA SPA; CAVAZZA CLAUDIO; SIGMA TAU INTERNATIONAL SA; Inverlochy Consultadoria & Servicos L.D.A.; Chaumiere Consultadoria & Servicos SDC Unipessoal LDA; CAVAZZA PAOLO","owner_display_name":"DEFIANTE FARMACEUTICA LDA","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, no par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2446782.0,"shares_display":"2,446,782","price_per_share":4.68,"price_display":"4.68","price_state":"stated","total_value":11450939.76,"total_display":"11,450,939.76","total_whole":"11,450,940","shares_owned_after":7248227.0,"shares_owned_after_display":"7,248,227","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-11-20","filed_date":"2007-11-23","scope":"insider"},{"id":3618103,"accession":"0001209191-06-066822","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-06-066822","line_url":"/filing/0001209191-06-066822","is_derivative":false,"issuer_cik":"0000891288","issuer_name":"QUESTCOR PHARMACEUTICALS INC","issuer_ticker":"QSC","issuer_name_source":null,"issuer_url":"/issuer/0000891288","owner_cik":null,"owner_name":"SIGMA TAU INTERNATIONAL SA; CAVAZZA PAOLO; Chaumiere Consultadoria & Servicos SDC Unipessoal LDA; Inverlochy Consultadoria & Servicos L.D.A.; DEFIANTE FARMACEUTICA LDA; APTAFIN S P A; SIGMA TAU FINANZIARIA SPA; CAVAZZA CLAUDIO","owner_display_name":"SIGMA TAU INTERNATIONAL SA","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, no par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9402890.0,"shares_display":"9,402,890","price_per_share":1.5,"price_display":"1.50","price_state":"stated","total_value":14104335.0,"total_display":"14,104,335.00","total_whole":"14,104,335","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-12-20","filed_date":"2006-12-22","scope":"insider","n_lines":4},{"id":3618095,"accession":"0001209191-06-066822","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-06-066822","line_url":"/filing/0001209191-06-066822","is_derivative":false,"issuer_cik":"0000891288","issuer_name":"QUESTCOR PHARMACEUTICALS INC","issuer_ticker":"QSC","issuer_name_source":null,"issuer_url":"/issuer/0000891288","owner_cik":null,"owner_name":"SIGMA TAU INTERNATIONAL SA; CAVAZZA PAOLO; Chaumiere Consultadoria & Servicos SDC Unipessoal LDA; Inverlochy Consultadoria & Servicos L.D.A.; DEFIANTE FARMACEUTICA LDA; APTAFIN S P A; SIGMA TAU FINANZIARIA SPA; CAVAZZA CLAUDIO","owner_display_name":"SIGMA TAU INTERNATIONAL SA","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, no par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9402890.0,"shares_display":"9,402,890","price_per_share":1.5,"price_display":"1.50","price_state":"stated","total_value":14104335.0,"total_display":"14,104,335.00","total_whole":"14,104,335","shares_owned_after":4321699.0,"shares_owned_after_display":"4,321,699","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-12-20","filed_date":"2006-12-22","scope":"insider","n_lines":4}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000707511","name":"REGENERX BIOPHARMACEUTICALS INC","url":"/issuer/0000707511","role":"Ten percent owner","n_filings":4,"first_seen":"2008-12-12","last_seen":"2009-10-13"},{"type":"issuer","type_label":"ISSUER","cik":"0000891288","name":"QUESTCOR PHARMACEUTICALS INC","url":"/issuer/0000891288","role":"Ten percent owner","n_filings":6,"first_seen":"2006-12-22","last_seen":"2008-08-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001330564","retrieved_at":"2026-08-22T23:27:10+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}